Opportunity Information: Apply for RFA 624 13 000002
Apply for RFA 624 13 000002
- The Ghana USAID Accra in the health sector is offering a public funding opportunity titled "Agir pour la Planification Familiale AGIR PF" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001 USAID Foreign Assistance for Programs Overseas.
- This funding opportunity was created on Oct 29, 2012 and posted on Oct 29, 2012.
- Applicants must submit their applications by Jan 8, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $29,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $29,000,000.00 in funding.
- The number of recipients for this funding is limited to 5 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
Agir pour la Planification Familiale (AGIR PF) was a USAID/West Africa regional health grant opportunity designed to expand access to and use of high-quality family planning services in targeted urban and peri-urban areas across four francophone West African countries: Burkina Faso, Mauritania, Niger, and Togo. The overall intent was to improve both the availability and the uptake of family planning information and services in settings where demand is growing and service delivery systems often face gaps in quality, reach, and consistent supplies.
The opportunity focused on three main program results. First, it aimed to strengthen and expand the delivery of quality family planning information, products, and services. In practical terms, that points to improving what clients receive at service delivery points and through outreach: better counseling and informed choice, improved provider performance and service readiness, and wider availability of modern contraceptive options. Second, AGIR PF emphasized adapting and implementing evidence-based service delivery approaches. This suggests that awardees were expected not just to deliver services, but to use proven interventions (and tailor them to local contexts) to increase effective coverage, quality, and continuity of use, particularly in busy urban and peri-urban environments. Third, the project aimed to coordinate efforts to remove policy barriers and improve contraceptive commodity security, meaning it would support collaboration with governments and partners to address regulatory or procedural obstacles and to reduce stock-outs through stronger forecasting, procurement coordination, and supply chain management so that contraceptives are reliably available where and when clients need them.
From a funding and administrative standpoint, AGIR PF was issued as a discretionary funding opportunity under a Cooperative Agreement, which typically indicates substantial USAID involvement during implementation, such as ongoing technical collaboration, joint planning, and performance oversight. The activity category was Health, with an estimated total funding amount of USD 29,000,000. Individual awards were expected to range from USD 15,000,000 (floor) up to USD 29,000,000 (ceiling), and USAID anticipated making up to five awards. There was no cost-sharing or matching requirement stated, and eligibility was listed as unrestricted, meaning a broad range of organizations could apply, subject to any additional eligibility clarifications contained in the full announcement.
Key dates show this was a time-bound solicitation posted on October 29, 2012, with an application deadline of January 8, 2013, and an archive date of February 7, 2013. The funding opportunity number was RFA-624-13-000002, associated with CFDA 98.001 (USAID Foreign Assistance for Programs Overseas). The issuing agency was listed as USAID in Accra (Ghana USAID/West Africa), reflecting the regional platform managing the activity. Applicants were directed to the full announcement via Grants.gov, and a named point of contact (Josephine Kitongo) was provided for support in accessing the materials.
AGIR PF (Agir pour la Planification Familiale) - Grant Opportunity FAQs
1) What is AGIR PF?
AGIR PF (Agir pour la Planification Familiale) was a USAID/West Africa regional health grant opportunity designed to expand access to and use of high-quality family planning services in selected urban and peri-urban areas in francophone West Africa.
2) What was the overall purpose of this funding opportunity?
The overall intent was to improve both the availability and the uptake of family planning information and services in settings where demand is growing and service delivery systems often face gaps in quality, reach, and consistent supplies.
3) Which countries were targeted?
The opportunity targeted four francophone West African countries: Burkina Faso, Mauritania, Niger, and Togo.
4) What types of geographic areas did the project focus on?
The focus was on targeted urban and peri-urban areas, where service delivery systems may be strained by population growth and high client volume, and where improving quality, coverage, and continuity of use can be especially important.
5) What activity area/category did this opportunity fall under?
The activity category was Health.
6) What were the main program results (key objectives)?
The opportunity centered on three main results: (1) strengthening and expanding the delivery of quality family planning information, products, and services; (2) adapting and implementing evidence-based service delivery approaches; and (3) coordinating efforts to remove policy barriers and improve contraceptive commodity security.
7) What did "strengthen and expand the delivery of quality family planning information, products, and services" mean in practice?
Based on the description provided, this pointed to improving what clients receive at service delivery points and through outreach, including better counseling and informed choice, improved provider performance and service readiness, and wider availability of modern contraceptive options.
8) What does it mean that the project emphasized evidence-based service delivery approaches?
It suggests awardees were expected not only to deliver services, but to use proven interventions and tailor them to local contexts to improve effective coverage, quality, and continuity of use, particularly in busy urban and peri-urban environments.
9) What did AGIR PF aim to do regarding policy barriers?
The project aimed to coordinate efforts to remove policy barriers by supporting collaboration with governments and partners to address regulatory or procedural obstacles that can limit access to family planning information and services.
10) What is meant by "contraceptive commodity security" in this opportunity?
In the context provided, it refers to efforts to reduce stock-outs and ensure contraceptives are reliably available where and when clients need them, including stronger forecasting, procurement coordination, and supply chain management.
11) What type of award mechanism was used?
The opportunity was issued under a Cooperative Agreement.
12) What does a Cooperative Agreement imply about USAID's involvement?
A Cooperative Agreement typically indicates substantial USAID involvement during implementation, such as ongoing technical collaboration, joint planning, and performance oversight.
13) What was the estimated total funding amount?
The estimated total funding amount was USD 29,000,000.
14) What was the expected award size range?
Individual awards were expected to range from USD 15,000,000 (floor) up to USD 29,000,000 (ceiling).
15) How many awards did USAID expect to make?
USAID anticipated making up to five awards.
16) Was cost-sharing or matching required?
No cost-sharing or matching requirement was stated in the information provided.
17) Who was eligible to apply?
Eligibility was listed as unrestricted, meaning a broad range of organizations could apply, subject to any additional eligibility clarifications contained in the full announcement.
18) What is the funding opportunity number?
The funding opportunity number was RFA-624-13-000002.
19) What CFDA number was associated with this opportunity?
The opportunity was associated with CFDA 98.001 (USAID Foreign Assistance for Programs Overseas).
20) Which USAID office issued the opportunity?
The issuing agency was listed as USAID in Accra, Ghana (USAID/West Africa), reflecting the regional platform managing the activity.
21) When was the opportunity posted?
The solicitation was posted on October 29, 2012.
22) What was the application deadline?
The application deadline was January 8, 2013.
23) When was the opportunity archived?
The archive date was February 7, 2013.
24) Where were applicants directed to find the full announcement?
Applicants were directed to the full announcement via Grants.gov.
25) Who was the point of contact listed for help accessing materials?
A named point of contact was provided: Josephine Kitongo, identified as a support contact for accessing the materials.
Browse more opportunities from the same category: Health
Next opportunity: Water Conservation Field Services Program Great Plains Region, Dakotas Area Office
Previous opportunity: Mexico Merida Initiative Diagnostic Study for the Drug Court in Guadalupe, Nuevo Len
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA 624 13 000002
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA 624 13 000002) also looked into and applied for these:
| Funding Opportunity |
|---|
| Alzheimers Disease Therapeutics Program (U01) Apply for RFA AG 13 014 Funding Number: RFA AG 13 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Epigenomics of Virus Associated Oral Diseases (R21) Apply for RFA DE 13 003 Funding Number: RFA DE 13 003 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Epigenomics of Virus Associated Oral Diseases (R01) Apply for RFA DE 13 002 Funding Number: RFA DE 13 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Collaborative Network for Clinical Research on Immune Tolerance (UM1) Apply for RFA AI 12 043 Funding Number: RFA AI 12 043 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Tuberculosis Research Units (U19) Apply for RFA AI 12 045 Funding Number: RFA AI 12 045 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AHRQ Conference Grant Program (R13) Apply for PA 13 017 Funding Number: PA 13 017 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Limited Competition Collaborative Partnership to Advance Global Biomedical Research Programs (U01) Apply for RFA AI 12 055 Funding Number: RFA AI 12 055 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Age Related Changes in Osteoimmunology (R01) Apply for RFA AG 13 017 Funding Number: RFA AG 13 017 Agency: National Institutes of Health Category: Health Funding Amount: $125,000 |
| FY13 FY14 Department of Defense HIV/AIDS Prevention Program Military Specific HIV/AIDS Prevention, Care, and Treatment Program for non PEPFAR (Presidents Emergency Plan for AIDS Relief) Funded Countries Apply for DHAPP BAA 13 001 Funding Number: DHAPP BAA 13 001 Agency: Naval Supply Systems Command Category: Health Funding Amount: Case Dependent |
| Service Area Competition Additional Area (SAC AA) Tuskegee, Alabama Apply for HRSA 13 260 Funding Number: HRSA 13 260 Agency: Health Resources and Services Administration Category: Health Funding Amount: $1,398,873 |
| Nurse Anesthetist Traineeship Program (NAT) Apply for HRSA 13 187 Funding Number: HRSA 13 187 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Medicare Rural Hospital Flexibility Program Evaluation Cooperative Agreement Apply for HRSA 13 164 Funding Number: HRSA 13 164 Agency: Health Resources and Services Administration Category: Health Funding Amount: $1,000,000 |
| Rural Health Research Dissemination Cooperative Agreement Apply for HRSA 13 165 Funding Number: HRSA 13 165 Agency: Health Resources and Services Administration Category: Health Funding Amount: $120,000 |
| FY13 FY14 Department of Defense HIV/AIDS Prevention Program Military Specific HIV/AIDS Prevention, Care, and Treatment Program for PEPFAR (Presidents Emergency Plan for AIDS Relief) Funded Countries Apply for DHAPP BAA 13 002 Funding Number: DHAPP BAA 13 002 Agency: Naval Supply Systems Command Category: Health Funding Amount: Case Dependent |
| NIMHD Transdisciplinary Collaborative Centers for Health Disparities Research U54 Apply for RFA MD 13 003 Funding Number: RFA MD 13 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Diffusion of Medical Technology and Effects on Outcomes and Expenditures (U01) Apply for RFA RM 12 023 Funding Number: RFA RM 12 023 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Enhancing GTEx with molecular analyses of stored biospecimens (U01) Apply for RFA RM 12 009 Funding Number: RFA RM 12 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Cooperative Program in Translational Research (U01) Apply for PAR 13 022 Funding Number: PAR 13 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Exploratory/Developmental Projects in Translational Research (R21) Apply for PAR 13 023 Funding Number: PAR 13 023 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Determinants and Consequences of Personalized Health Care and Prevention (U01) Apply for RFA RM 12 024 Funding Number: RFA RM 12 024 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA 624 13 000002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.